NCT06272825 is a NA clinical trial of Virtual reality in Knee Osteoarthritis, sponsored by Kirsehir Ahi Evran Universitesi.

Who is sponsoring NCT06272825?

NCT06272825 is sponsored by Kirsehir Ahi Evran Universitesi.

What drugs are being tested in NCT06272825?

Interventions in NCT06272825: Virtual reality, conventional rehabilitation.

What condition does NCT06272825 study?

NCT06272825 studies Knee Osteoarthritis, Pain, Quality of Life.

Is NCT06272825 still recruiting?

NCT06272825 is currently recruiting now. Last updated 2 August 2024.

Last reviewed 2024-08-02 · How we verify

NCT06272825

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Virtual Reality in Patients With Knee Osteoarthritis

Recruiting now NA Last updated 2 August 2024

What this trial tests

NA trial testing Virtual reality in Knee Osteoarthritis in 40 participants. Currently enrolling.

Timeline

28 May 2024

Primary endpoint
14 December 2024

14 January 2025

Quick facts

Lead sponsor	Kirsehir Ahi Evran Universitesi
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	40
Start date	28 May 2024
Primary completion	14 December 2024
Estimated completion	14 January 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Virtual reality
conventional rehabilitation

Conditions studied

Knee Osteoarthritis — all drugs for Knee Osteoarthritis →
Pain — all drugs for Pain →
Quality of Life — all drugs for Quality of Life →

Sponsor

Kirsehir Ahi Evran Universitesi — full company profile →

Who can join

Adults 40 to 85, any sex, with Knee Osteoarthritis or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

One of the main challenges facing the therapist in the treatment of adhesive capsulitis is to motivate the patient throughout conventional therapy. As noted in a recent review, individuals are more interested in leisure activities rather than performing repetitive tasks during therapy. Virtual reality (VR) is a three-dimensional computer-aided programme built with a system that creates virtual reality movements and generates a high amount of visual and sensory feedback during exercise. As a result, virtual reality (VR) has been used in many medical indications and has been shown to promote adherence to treatment by increasing patient motivation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Virtual reality

Trials testing the same drug.

NCT06955338 — Music and VR Effects on Pain, Anxiety, and Fear During Oral Mucositis Care in Leukaemic Children · NA · not yet recruiting
NCT07408622 — Virtual Reality Therapy for Wrist and Hand Injury Recovery · NA · not yet recruiting
NCT07483866 — The Effectiveness of a Virtual Reality-based Educational Intervention on Anxiety Symptoms, Pain Levels, and Physiologica · NA · not yet recruiting
NCT07371260 — Effects of Virtual Reality With Multisensory Stimulation on Emotional and Behavioral Disorders in Individuals With Acqui · NA · not yet recruiting
NCT07343843 — Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes Duri · NA · recruiting

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting

Other Kirsehir Ahi Evran Universitesi trials

Trials by the same sponsor.

NCT07506915 — The Effect of Cognitive Behavioral Therapy · NA · enrolling by invitation
NCT07502248 — PENG Block With or Without PPD Block for Postoperative Analgesia After Total Hip Arthroplasty · NA · not yet recruiting
NCT07438392 — Tecar Therapy in Chronic Knee Osteoarthritis · NA · not yet recruiting
NCT07450742 — Digital Storytelling and Mother's Knowledge and Attitudes Towards Newborn Screning · NA · not yet recruiting
NCT07414017 — Comparison of Focus of Attention in Virtual Reality-Based Exercise Training in Older Adults With Low Back Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06272825 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kirsehir Ahi Evran Universitesi
Last refreshed: 2 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06272825.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing